ACQUISITION AND RELATED PARTY ITEMS - Additional Information (Details) - USD ($)					3 Months Ended		6 Months Ended	9 Months Ended
	Jan. 03, 2022	Sep. 01, 2021	Jul. 01, 2021	Feb. 01, 2021	Sep. 30, 2022	Mar. 31, 2022	Jun. 30, 2022	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021	Feb. 21, 2021
Business Acquisition [Line Items]
Payment of Notes Payable								$ 2,385,000	$ 0
Goodwill					$ 129,960,000			129,960,000		$ 118,826,000
Operating lease right-of-use assets					$ 6,810,000			$ 6,810,000		$ 5,198,000
Biotech
Business Acquisition [Line Items]
Ownership percentage					70.25%			70.25%
Additional ownership interest acquired					5.25%			5.25%
Biotech | Chinta Lamichhane, DVM, Ph.D
Business Acquisition [Line Items]
Ownership percentage					29.75%			29.75%
VetZ GmbH
Business Acquisition [Line Items]
Percentage of voting interest acquired	100.00%
Cash consideration transferred	$ 31,627,000
Business Combination, Contingent Consideration, Liability, Term	18 months
Business Combination, Contingent Consideration, Earn-Out	$ 15,500,000
Business Combination, Contingent Consideration, Liability, Fair Value	3,900,000
Working capital adjustment	$ 600,000
Additional consideration (in shares)	91,039
Business combination, contingent consideration, liability	$ 1,400,000
Goodwill	22,148,000
Purchase price	35,487,000
Operating lease right-of-use assets					$ 2,200,000			$ 2,200,000
Operating Lease, Liability					2,200,000			2,200,000
Revenue of acquiree since acquisition date						$ 9,000,000
Acquisition related costs					0			700,000
Operating Lease, Expense					47,000			199,000
Net income of acquiree since acquisition date						$ 1,500,000
Acquisition receivables	$ 165,000
Biotech
Business Acquisition [Line Items]
Percentage of voting interest acquired		65.00%
Cash consideration transferred		$ 16,250,000
Remaining percentage of interest to be acquired		35.00%
Payment of Notes Payable								2,600,000
Reduction to notes payable								2,400,000
Interest expense related to Notes Payable								200,000
Notes Payable, Fair Value Disclosure		$ 15,900,000			13,500,000			13,500,000
Business combination, contingent consideration, liability					14,900,000			14,900,000
Goodwill		25,822,000
Purchase price		$ 32,150,000
BiEsseA s.r.1.
Business Acquisition [Line Items]
Cash consideration transferred			$ 4,835,000
Business combination, contingent consideration, liability			2,500,000
Goodwill			4,562,000
Purchase price			7,169,000
Unrecognized tax benefits, decrease resulting from acquisition								500,000
Business Acquisition, Goodwill, Expected Tax Deductible Amount			$ 4,600,000
Business Combination, Indemnification Assets, Amount Outstanding					400,000			400,000
Lacuna Diagnostics, Inc.
Business Acquisition [Line Items]
Percentage of voting interest acquired											100.00%
Cash consideration transferred				$ 4,255,000
Business Combination, Contingent Consideration, Liability, Fair Value				1,700,000			$ 0	0
Business combination, indemnification liabilities, holdback				$ 400,000	0			0
Business combination, indemnification liabilities, holdback release period				18 months
Business combination, contingent consideration, liability				$ 2,000,000
Business acquisition, initial earn out period				12 months
Business combination, contingent consideration arrangements, liability performance reduction				$ 1,000,000
Fair value of contingent consideration				1,700,000
Goodwill				4,200,000
Purchase price				5,955,000
Business Acquisition, Goodwill, Expected Tax Deductible Amount				0
Business Combination, Indemnification Liabilities, Holdback Released					$ 300,000			$ 300,000
Lacuna Diagnostics, Inc. | North America
Business Acquisition [Line Items]
Goodwill				$ 4,200,000